REDHILL BIOPHARMA LTD. (RDHL) Operating income 2015–2024
REDHILL BIOPHARMA LTD. (RDHL) annual operating income history from SEC filings — each fiscal year as reported.
-$14.6MFY2024 · since FY2015: -$22.0M → -$14.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$14.6M | -215.7% |
| FY2023 | $12.6M | +129.5% |
| FY2022 | -$42.8M | +47.2% |
| FY2021 | -$81.1M | -27.4% |
| FY2020 | -$63.7M | -47.4% |
| FY2019 | -$43.2M | -9.8% |
| FY2018 | -$39.3M | +24.3% |
| FY2017 | -$52.0M | -70.2% |
| FY2016 | -$30.5M | -38.8% |
| FY2015 | -$22.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice